Matrix metalloproteinase (MMP)-assisted siRNA treatment was accomplished with a nanofibrous matrix for suicidal gene therapy of diabetic ulcers. We fabricated a MMP-responsive nanofibrous matrix to control release of small interfering RNA (siRNA) in response to a high concentration of MMPs in diabetic ulcers. For MMP-responsive release of siRNA, linear polyethyleneimine (LPEI) was chemically conjugated on the surface of the nanofibrous matrix via a MMP-cleavable linker. To control the abnormally elevated MMP-2 expression in diabetic ulcers, MMP-2 siRNA was electrostatically incorporated into LPEI-immobilized nanofibrous meshes with various nitrogen/phosphate (N/P) ratios. The release profiles of siRNA and LPEI were monitored to confirm that MMP responsiveness of the matrix and MMP-2 significantly increased the release of both siRNA and LPEI for 72 h. The released fractions were transfected to dermal fibroblasts. Quantitative reverse transcription (qRT)-PCR for endogenous MMP-2 expression confirmed that the gene-silencing effects of siRNA were dependent on the charge ratio of LPEI to siRNA on the mesh. Diabetic animals with dorsal burns were treated with siRNA-incorporated nanofibrous mesh for 7days. siRNA-incorporated nanofibrous meshes dramatically increased the MMP-2 gene-silencing effects of the siRNA and neo-collagen accumulation at the wound sites. RT-PCR also confirmed the highest expression levels of the keratinocyte-specific markers and the lowest expression levels of MMP-2 in the nanofibrous mesh-treated groups, suggesting that wound recovery is restored to normal levels. The wound recovery rates of diabetic ulcers were significantly increased when siRNA-incorporated nanofibrous meshes were administered. Thus, the suicidal treatment with the MMP-2 siRNA-decorated nanofibrous mesh is expected to improve prognosis of diabetic ulcers with reduced side effects.
INTRODUCTION
Diabetic foot lesion is one of the major symptoms in diabetic patients with a high frequency and intensity in the population, which leads to a higher rate of hospitalization than any other diabetic complications. [1] [2] [3] Numerous physiological and mechanical changes in the lesion are considered to be responsible for impaired wound recovery at the wound sites. Among those, many researches indicated that retarded remodeling process is caused by abnormally elevated levels of a matrix metalloproteinase (MMP), a superfamily of proteases degrading most extracellular matrix (ECM). [4] [5] [6] In non-diabetic wounds, they have a pivotal role of remodeling defected tissues by increasing the migration of fibroblasts and endothelial cells of the connective tissues. Their expression levels are tightly controlled to remove denatured fibrillar collagen and assist proper development of granulation tissues during the wound-healing process; their activities are increased in the early healing phase and then decreased as the healing process completes. In patients with diabetes mellitus symptoms, however, the average concentration of active MMP-2 is abnormally increased to 103±180 pg/ml À 1 , which is six times higher than that of non-diabetic individuals. 4 Consequently, the breakdown rates of matrix proteins such as collagen and elastin override the remodeling rates of the defected tissues because of the higher activities of MMPs. Treatment of the attenuated re-epithelization was challenging because many growth factors, including epidermal growth factor, basic fibroblast growth factor and transforming growth factor-b, showed limited effectiveness towards highly active MMPs and other hydrolytic enzymes. [7] [8] [9] In order to overcome rapid inactivation of growth factors, gene therapy was recently introduced to express therapeutic growth factors at the wound site. [10] [11] [12] A thermosensitive hydrogel composed of triblock copolymers encapsulating plasmid TGF-b1 significantly accelerated re-epithelialization, cell proliferation and collagen synthesis in diabetic animal models. 11 A human epidermal growth factor-expression plasmid was fabricated into 1-3-mm-sized gold particles for transfection of porcine wounds. 12 The re-epithelization period was decreased by 2 days compared with control groups, suggesting a significant acceleration of healing rates owing to high levels of epidermal growth factor expression.
Local delivery of small interfering RNA (siRNA) has been extensively explored for treatment of malignant tumors, infectious diseases and genetic disorders. [13] [14] [15] Although systemic delivery is the most common route of siRNA administration, locally delivered genetic materials were shown to effectively silence the targeted genes when lesions are localized in specific regions. siRNA polyplex or naked-siRNA pharmaceutics were directly administered to diverse organs such as subretinal regions, 16 tumors, reported, which can further facilitate siRNA delivery efficacy. Nanoparticulated siRNA was delivered to regional carotid artery walls and efficiently prevented restenosis after angioplasty in an atherosclerotic rat model. 20 In another study, biodegradable hydrogels encapsulating siRNA were intramuscularly administered to mice and they showed that ectopic bone formation was increased compared with bone morphogenetic protein-treated control groups. 21 In those studies, the gene-silencing effects of the administered siRNA were restricted to the local lesions because of the short half-life of the administered siRNA. Local delivery of siRNA has a number of advantages, such as controlling off-target effects of gene silencing owing to systemic circulation, as well as minimizing siRNA therapeutic doses for cost-effectiveness.
We previously reported that electrospun nanofibrous meshes can be tailored for wound dressing candidates containing multiple growth factors and cytokines. 22, 23 Owing to their super-nanoporous architecture, the nanofibrous meshes were employed as 'wetdressing' materials with high moisture and oxygen transport through the pores, while they also act as barriers for bacterial infiltration. Multiple growth factors such as epidermal growth factor and basic fibroblast growth factor were surface-immobilized on the surface of the nanofiber, which improved wound-healing rates and reduced scar formation. 23 We also prepared a MMPresponsive nanofibrous matrix to control release of DNA in response to a high concentration of MMPs in diabetic ulcers. 24 Plasmid DNA encoding a green fluorescence protein was efficiently incorporated into linear polyethyleneimine (LPEI) immobilized on the matrix. As MMP cleavable linkers between LPEI and the matrix were cleaved by MMP-2, the plasmid DNA/ LPEI complexes were subsequently released from the matrix. In the present study, we fabricated LPEI-immobilized surfaces on the electrospun nanofibrous meshes. For MMP responsiveness, LPEI moieties were anchored to the nanofibrous meshes via MMP cleavable peptides. The MMP-2 siRNA-incorporated LPEI nanofibrous mesh was tested for controlling the remodeling rates of ECM and wound-healing efficacy in diabetic ulcers. Figure 1 shows a schematic diagram of preparing siRNAincorporated MMP-responsive nanofibrous meshes, and a suicidal pathway of treating diabetic ulcers by the MMP-inspired nanofibrous meshes. In order to control the release of siRNA by the overexpressed MMPs in diabetic ulcers, a MMP-cleavable substrate, a heptapeptide composed of DGPLGVC, was employed as a linker for immobilizing LPEI on the nanofibrous mesh ( Figure 1a) . In diabetic ulcers, as many researchers have previously shown, MMP levels are abnormally higher than those of nondiabetic wounds by 5-30-fold, which is considered to be a major cause of the impaired wound recovery in diabetic ulcers. [4] [5] [6] Thus, we speculate that the liberation of siRNA/LPEI complex is dependent on the MMP levels, because LPEI was tethered to the nanofibrous meshes by a MMP-cleavable linkage. Many researchers have previously shown that MMP levels are abnormally higher in diabetic ulcers than in non-diabetic wounds. MMPs are involved in ECM remodeling and degradation for cell penetration and angiogenesis during the wound-healing process. A balance between degradation and regeneration of wound bed is important for correct wound healing. However, ECM degradation rate is much faster than regeneration rate because of highly expressed MMPs in diabetic ulcers, which lead to delayed wound coverage. Thus, impaired wound healing frequently develops to chronic non-healing ulcers, like a diabetic foot lesion, which is a major symptom of diabetic patients. Thus, we speculated that MMP-2 siRNA downregulates MMP expression in diabetic ulcers so that the wound-healing process can be accelerated, which is the so-called 'suicidal treatments' for diabetic ulcers. The released MMP-2 siRNA subsequently downregulates MMP-2 expression, and the decreased MMP-2 level at the wound sites clearly accelerates the remodeling rates of ECM, because major constituents of ECM such as collagen and elastin are less likely to be degraded (Figure 1b) . The surface-exposed amine groups on the nanofibrous meshes were quantitatively measured in aqueous phase by a fluorescamine assay. The density of the amine groups per mg nanofibrous meshes was confirmed to be 0.434 nmol mg À 1 . After LPEI conjugation via a MMP-cleavable linker, the presence of LPEI on the nanofibrous meshes was determined by X-ray photoelectron scattering spectroscopy. The LPEI-immobilized nanofibrous mesh (NF) clearly showed a distinctive peak of nitrogen atoms (N 1s ) at 399 eV, while those without LPEI did not show any peaks of nitrogen atoms. The amounts of LPEI can be quantitatively determined by comparing the nitrogen peak intensity to the oxygen peak intensity (O 1s ) at 530 eV, which confirmed that the amount of conjugated LPEI was 0.173 nmol mg À 1 (4.3 mg mg À 1 ) (Supplementary Figure S1) .
RESULTS AND DISCUSSION
siRNA/LPEI nanofibrous meshes with different nitrogen/phosphate (N/P) ratios were prepared and the incorporation efficiencies of siRNA were evaluated on the LPEI NF (Table 1) . In order to maintain desired N/P ratios on the mesh with a fixed amount of LPEI, we gradually decreased the amount of siRNA when N/P ratios became higher; the amounts of incorporated siRNA were decreased when N/P ratios increased. NFs with higher N/P ratios consequently had smaller amounts of incorporated siRNA compared with those with lower ratios, for example, NF 4 had 0.93 nmol of incorporated siRNA per device, while NF 16 had only 0.15 nmol per device. However, the incorporation efficiencies (the ratio of incorporated amounts of siRNA to the initial amount) were maintained at 77-82% independently of changes in N/P ratio. This is noticeable because we previously observed that the incorporation efficiency clearly increased according to the increase in N/P ratio when plasmid DNA was incorporated into the same mesh. 24 We speculate that the low-molecular-weighted siRNA with [19] [20] [21] [22] [23] base pairs caused the independency of the charge ratios with respect to the incorporation efficiencies. In contrast to plasmid DNA with several hundred base pairs, siRNA does not have strong anionic charge densities compared with DNA molecules. Thus, even though the charge ratios of LPEI and siRNA increased from 4 to 32, the incorporation efficiency of siRNA remained at the same level. Low anionic densities of siRNA subsequently cause weaker electrostatic interactions between the matrix and the nucleic acids. Thus, in order to maximize the incorporation efficiency, we directly dropped concentrated siRNA solutions (30 ml) on the nanofibrous meshes rather than soaking the mesh in siRNA solutions. Using this strategy, we successfully obtained higher incorporation efficiency of siRNA even after extensive washing, which has a similar value to that obtained by plasmid DNA incorporation. Several studies also indicated that soaking polymeric carriers in siRNA solution did not enhance siRNA binding to the LPEI-modified surfaces. 25, 26 It should also be noticeable that siRNA was not physically adsorbed to the nanofibrous mesh without LPEI even though the mesh has a high surface-to-volume ratio (data not shown). Thus, this result clearly suggests that siRNA is electrostatically incorporated into LPEI-immobilized surfaces of the nanofibrous mesh, rather than non-specific hydrophobic interactions between the matrix and siRNA.
In order to determine the effects of MMP-2 on the release profiles of siRNA and LPEI from the mesh, the matrix was incubated in MMP-2-containing medium and the released amounts of fluorescein isothiocyanate (FITC)-siRNA and LPEI were monitored for 72 h ( Table 2 ). In the presence of MMP-2 in the release medium, considerable amounts of FITC-siRNA and LPEI were released from all NFs. In the absence of MMP-2, however, the release behaviors of FITC-siRNA and LPEI were relatively limited to 9% and 3%, respectively. MMP-2 dependency of the release profiles clearly suggests the MMP-responsive linker was enzymatically cleaved and the cargos were subsequently liberated from the matrix. Moreover, the release behaviors of siRNA and LPEI also showed a considerable correlation with their charge ratios between LPEI and siRNA, where NFs with higher N/P ratios showed the attenuated release profiles of LPEI and siRNA. Owing to the higher cationic charges of NFs at higher N/P ratios, the released siRNA is very likely to be re-associated with the surfacedecorated LPEI of the nanofibrous meshes. Even though MMP-2 specifically cleaved off the linkage between the matrix and LPEI, 75-78% of the LPEI was yet anchored to the mesh irrespective of their charge ratios, as shown in Table 1 , the values shown in which are enough to render the higher cationic charge density on the surface of the mesh.
The extent of intracellular uptakes and in vitro transfection efficiency of the fractions released from the nanofibrous mesh were examined in human dermal fibroblasts (HDFs) as shown in Figure 2 . When HDFs were treated with FITC-siRNA/LPEI fractions siRNA nanofibrous meshes for wound healing HS Kim and HS Yoo at various N/P ratios, the transfected cells showed different fluorescence intensities as a function of the N/P ratios: the higher the N/P ratios that the NFs had, the higher the intensity of FITCsiRNA observed. The internalized FITC-siRNA/LPEI complex was predominantly localized in the cytosolic regions, which normally resulted from cellular endocytosis. Based on this result, we could speculate that FITC-siRNA was electrostatically complex with an adaptor molecule, the liberated LPEI from the matrix and formed a nanoparticle in the same way that LPEI and nucleic acids forms a complex. Figure 2b shows quantitative RT-PCR (qRT-PCR) results with MMP-2 siRNA, which also confirmed that the gene-silencing effects according to the N/P ratios, where the NF 32 exerted superior effects on dicer-assisted degradation of MMP-2 mRNA to other NFs. When the fold expression levels of MMP-2 mRNA were measured with respect to those of the house-keeping gene, a GAPDH, NF 32 showed approximately 10 times higher genesilencing effects compared with NF 16. This suggested that higher N/P ratios are advantageous for endocytic uptakes of cells, which coincides with many studies that have employed cationic polymers for gene delivery. The release of siRNA and LPEI from an electrostatic complex and the electrostatic strength between the oppositely charged molecules increase in proportion to N/P ratios. According to the studies employing siRNA gene carriers, siRNA was confirmed to efficiently transfect cells when N/P ratios were X8. 13, 27 It should be noticed that each fraction of the siRNA/LPEI complex does not contain the same amount of siRNA because we controlled N/P ratios by decreasing the amounts of siRNA, not by increasing LPEI. Thus, we concluded that although the amount of siRNA in the meshes was decreased as the N/P ratio increased, the transfection efficiency was increased, clearly suggesting that the charge ratios of the NF, rather than the incorporated amounts of siRNA, predominantly affected in vitro transfection efficiencies.
Inspired by in vitro gene silencing by the MMP-2 siRNAincorporated NFs, we determined the in vivo wound-healing efficacy of the MMP-2 siRNA-incorporated NFs; the NF 32 was administered at the dorsal burns of the model animals with diabetes mellitus-like symptoms. Figure 3 shows immunohistological staining results against MMP-2 of the treated wounds at days 3 and 7. At day 3, the intensity of MMP-2 antibody staining did not change among the treated groups, suggesting that MMP-2 siRNAincorporated NF or MMP-2 siRNA did not silence the expression of MMP-2 (Figures 3a-d) . However, at day 7, the gene-silencing effects were clearly visualized in the animals treated with NF 32 (Figure 3e ), compared with other groups (Figures 3f-h) . Thus, this result clearly showed that MMP-2 siRNA on NF 32 was cleaved by overexpressed MMP-2 at wound sites and subsequently shut down expression of MMP-2 for 1 week. We previously demonstrated that MMP-2 responsive linkers were more efficiently siRNA nanofibrous meshes for wound healing HS Kim and HS Yoo cleaved and the incorporated DNA on nanofibrous meshes was consequently liberated in diabetic wounds than in non-diabetic wounds. 24 Additionally, we presume that the dramatic increase of gene-silencing effects at day 7 is caused by a complexity of the wound recovery process. Because we excised the dorsal burn to full thickness to eliminate dead tissues of whole dermis before further treatments, few cells can be transfected with the release of the siRNA/LPEI complex upon treatment of NFs until day 3. However, after the inflammation period of the initial 3 days, fibroblasts and keratinocytes migrate and proliferate in a large number, which results in an overwhelming regeneration of dermal layers. 5 Thus, after the critical period of 3 days, those cells proliferate to a number enough to be transfected with the siRNA/ LPEI complex from NF 32. However, the naked siRNA is vulnerable to enzymatic degradation at the wound sites and showed inferior gene-silencing effects to NF 32 ( Figure 3f ). Numerous studies employing gene carriers for siRNA also showed that nanoparticulated siRNA is superior to the naked one in terms of the in vitro and in vivo half-life of siRNA. [28] [29] [30] [31] As MMPs break down ECM composed of collagen and other matrix proteins, assessing the regeneration rates of collagen matrix can clearly show the effects of MMP-2 gene silencing on the wound-recovery process. We here stained the tissue sections of the treated wounds with a collagen-specific dye at days 3 and 7. The re-epithelialized wound treated with NF 32 showed the most intense staining of collagen-specific dyes (blue) compared with other groups at day 7, as well as well-organized and thick collagen layers ( Figures 4A and e) . Figure 4B shows quantification of neocollagen in the wound area, which also confirmed that the accumulation of neo-collagen fibers was superior in NF 32 by 3.5-fold times compared to no treatment control. This result strongly suggests that the breakdown rate of collagen matrix was substantially attenuated when NF 32 was administered to the diabetic ulcers, which was caused by decreased expression levels of MMPs. The released MMP-2 siRNA and LPEI complex was endocytosed by fibroblasts and keratinocytes at the wound bed, and siRNA-coupled cytosolic MMP-2 mRNA was enzymatically cleaved by dicers. Notably, the results at day 3 did not show dramatic differences among the treated groups, which coincide with the results of MMP-2 immunostaining. Until day 3, the regeneration of the injured tissue was marginal and few cells were transfected by NF 32 or MMP-2 siRNA. However, the dermal layers containing fibroblasts and keratinocytes actively proliferate and neo-collagen synthesis rapidly occurs when the wound-healing process passes the inflammation period, which is a critical period for remodeling of ECM. During this period, siRNA/LPEI complex transfects large numbers of dermal cells and the siRNA-transfected dermal cells excrete decreased levels of MMPs, suggesting that abnormal degradation of collagen matrix can be prevented. Collagen matrix in the wound bed accordingly has a pivotal role in providing optimized environments for cell infiltration and consequently improves re-epithelization in the affected individual.
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In vivo expression levels of MMP-2 and keratin-specific markers (keratins 5 and 14) were measured at day 3 and day 7 post treatment ( Figure 5 ). In Figure 5b , the band intensities of MMP-2, keratin 5 and keratin 14 were quantitatively compared with those of the housekeeping gene, GAPDH, based on Figure 5a . When the diabetic wounds were treated with NF 32, keratin 5 and keratin 14 showed the highest expression levels, whereas lowest expression levels of MMP-2 were observed among the groups at both day 3 and day 7. This outcome coincides with our results, where the in vitro expression of MMP-2 was suppressed by MMP-2 siRNA/ LPEI of the NF 32. Expression levels of keratin 5 and 14 were more dramatically shown at day 7 in comparison with those at day 3. Many studies have previously indicated that expression of keratin is dependent on the epidermal layer, wherein keratin 14 is more actively expressed in the deeper layer than in the layer where keratin 5 is dominantly expressed. Thus, overall expression levels of keratin 14 were higher than those of keratin in most groups. Figure 6 shows wound-recovery rates of diabetic ulcers treated with respective groups. NF 32 and siRNA solution showed faster wound-recovery rates compared with NF and the control groups; however, NF 32 showed better wound recovery rates compared with siRNA solution with a statistical significance. Thus, this result clearly suggests that suicidal treatments of MMP-2 siRNA can be effective for those with abnormally elevated levels of MMPs at the wound sites. Because the release rates of MMP-2 siRNA can be controlled by cleavages of MMP-responsive linkers between LPEI and nanofibrous mesh, we suggest that MMP-2 siRNA-incorporated NF is better for in vivo application in terms of reducing side effects. Unwanted MMP-2 gene silencing can lead to improper wound-healing outcomes because migration of dermal cells is normally required for the normal wound-healing process, which is facilitated by the action of MMPs at the wound bed.
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MATERIALS AND METHODS Materials
Poly (e-caprolactone) (PCL) (Mw 70 000-100 000) was purchased from Wako Chemicals (Osaka, Japan). Bi-functional PEG (PEG-(amine) 2 
Synthesis of PCL-PEG block copolymer
Amine-terminated PCL-PEG block copolymer was synthesized by conjugating hydroxyl groups of PCL to PEG bis-amines as in our previous study. 24 Briefly, pyridine (45 mg) and p-nitrophenylchloroformate (60 mg) were added to PCL (12 g) in dichloromethane (60 ml) (molar ratio ¼ 4:2:1) at 0 1C and the mixture was reacted at room temperature. After 3 h, the reaction mixture was precipitated in an ice-cold diethyl ether and dried. The activated PCL (10 g) in dichloromethane was added to the activated PEG (1.2 g) in dichloromethane with vigorous stirring and further incubated at room temperature for 24 h (molar ratio of PCL:activated PEG ¼ 1:5). The mixture was precipitated in ice-cold ethanol (95%) and then completely dried. The conjugation efficiency of the synthesized PCL-PEG block copolymer was confirmed by 1 H-NMR spectroscopy in CDCl 3 at the central laboratory of Kangwon National University (Bruker, DPX 400 MHz).
Fabrication and characterization of electrospun nanofibrous mesh
The synthesized block copolymer was dissolved at a polymeric concentration of 10% (w/v) in a mixture of methanol and chloroform (1:3, v/v). The polymer solution was electrospun at 15 kV at a constant flow rate of 1 ml h À 1 through a 27-G needle. Electrospun fibrous meshes were collected on an aluminum ground with a ground-to-needle distance of 15 cm. The morphology of the PCL-PEG electrospun nanofibers was examined by field emission scanning electron microscopy (Hitachi, S-4300, Tokyo, Japan). The amount of the surface-exposed amine groups on the electrospun nanofiber was determined by a fluorescamine assay as described in the previous study. 24 Briefly, an electrospun nanofibrous mesh (1 mg) was immersed in 30% ethanol (20 ml) and subsequently hydrated in phosphate-buffered saline (1 ml, PBS, pH 7.4). Fluorescamine in acetone (0.3 mg ml À 1 , 100 ml) was added to the hydrated nanofibrous mesh and siRNA nanofibrous meshes for wound healing HS Kim and HS Yoo then reacted at room temperature for 30 min. After extensive washing with methanol, the reacted meshes were completely dissolved in 1,4-dioxane and the fluorescence intensities were measured (l ex ¼ 390 nm, l em ¼ 475 nm) (Perkin Elmer, LS-55B, Waltham, MA, USA). Ethylene diamine was employed as a standard material for quantification of the primary amine groups.
LPEI immobilization on the nanofibrous meshes surface LPEI was tethered to the surface-exposed amine groups of the hydrated nanofibrous meshes by a MMP-cleavable linker. 24 A MMP-cleavable peptide, EDC and NHS were added to the electrospun nanofibrous meshes in PBS-EDTA (pH 7.4) (1 ml) (molar ratio of the peptide:EDC:NHS ¼ 1:10:10). The feeding amount of a MMP-cleavable peptide was adjusted with respect to the surface-exposed amine groups, where the molar ratio of the peptide to the amount of surface-exposed amine groups was kept at 1:1 (0.434 nmol mg À 1 ). The reaction was performed at 37 1C for 2 h, which was followed by extensive washing with distilled water. LPEI in PBS-EDTA (1 ml) was activated with 20 mM N-succinimidyl-3(2-pyridyldithio) propionate at room temperature for 30 min and transferred to the peptide-immobilized nanofibers (molar ratio of LPEI:peptide ¼ 1:1). The reaction was performed at room temperature for 12 h and the LPEI-immobilized nanofibrous meshes were washed with PBS and then completely dried. The amount of conjugated LPEI on the nanofibrous mesh was measured by X-ray photoelectron scattering spectroscopy (Thermo Scientific, ESCA-2000, Waltham, MA, USA). The nanofibrous meshes were scanned with non-monochromatic Al Ka radiation and survey scan spectra were obtained. The degree of LPEI conjugation on the nanofibers was calculated by comparing the N 1s peak intensity with respect to the C 1s peak intensity or the O 1s peak intensity.
Incorporation of siRNA to the LPEI nanofibrous meshes siRNA against MMP-2 was synthesized and electrostatically incorporated to LPEI-immobilized surfaces of the nanofibrous meshes. MMP-2 siRNA and FITC-siRNA were purchased from Bioneer (Daejeon, South Korea). The sequences of MMP-2 siRNA inhibiting expression of human MMP-2 were 5 0 -CUGCAAACAGGACAUUGUA-3 0 (sense) and 5 0 -UACAAUGUCCUGUUUG CAG-3 0 (antisense). The sequences of MMP-2 siRNA inhibiting murine MMP-2 expression were 5 0 -CUUUUUGUGCCCAAAGAAA-3 0 (sense) and 5 0 -UUUCUUUGGGCACAAAAAG-3 0 (antisense). siRNA solution (30 ml) was slowly dropped on the pre-wetted nanofibrous meshes according to various N/P ratios and further incubated at room temperature with gentle shaking for 4 h. In order to measure the incorporation efficiencies of siRNA, the nanofibrous meshes with FITC-siRNA were washed with PBS three times and the amount of free siRNA in the washing solution was fluorescently determined at an excitation wavelength of 480 nm and an emission wavelength of 510-530 nm (Perkin Elmer, LS-55B). Unmodified nanofibrous meshes (PCL-PEG) were employed to measure the basal levels of siRNA adsorption on the meshes without LPEI.
Release study
The amount of LPEI and FITC-siRNA released from the MMP-responsive nanofibrous mesh was examined at 72 h. LPEI-immobilized meshes (1 mg, n ¼ 5) were incubated at 37 1C with a vigorous shaking at 280 r.p.m. in the presence or absence of MMP-2 (molar ratio of MMP-cleavable peptide:MMP-2 ¼ 1:1) in PBS (5 ml). The amount of released LPEI was quantified using an APA reagent as described in the previous study. 24 Briefly, the APA reagent was mixed with the released fractions by vigorous vortexing for 5 s and further incubated at room temperature for 30 min (sample: 5 Â APA solution ¼ 4:1 (v/v)). The absorbance of the reaction mixture was measured at 590 nm and the amount of released LPEI was determined by employing N-succinimidyl-3(2-pyridyldithio) propionate-activated LPEI as a standard. In order to quantify the released FITC-siRNA, the fluorescence intensity of the release medium was measured at an excitation wavelength of 480 nm and an emission wavelength of 530 nm.
In vitro transfection
HDFs were cultured in DMEM with LSGS and streptomycin/penicillin. For transfection studies, cells were seeded on a 12-well plate at a density of 1 Â 10 5 cells per well and allowed to attach for 24 h. The culture medium was replaced with fresh serum-free DMEM containing released FITC-siRNA/ LPEI complex at 72 h (0.1 ml) and incubated for 5 h. Cells were fixed with 1 wt% paraformaldehyde and observed with a confocal laser scanning microscopy at the Korea Basic Science Institute (Carl Zeiss, LSM510, Oberkochen, Germany). The fluorescence intensities of the confocal microscopic images (n ¼ 3) were quantified by an image analysis software (Media Cybernetics, Image-Pro v6.0, Bethesda, MD, USA). In order to determine the inhibition levels against MMP-2, the released MMP-2 fractions from the siRNA-incorporated LPEI nanofibrous meshes were also employed for transfections. After incubation with LSGS-free DMEM containing MMP-2 siRNA/LPEI complex for 5 h, the cells were fed again with fresh culture medium containing LSGS and cultured for an additional 24 h. To determine MMP-2 gene inhibition, a quantitative RT-PCR analysis was performed after transfection. The total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA, USA) and qRT-PCR was performed using a SuperScriptTM III Platinum SYBR Green one-step qRT-PCR kit. The reaction was performed as follows: cDNA synthesis was performed at 50 1C for 10 min, denatured at 95 1C for 5 min, followed by 40 cycles of 95 1C for 10 s and 55 1C for 30 s. The primers are detailed in Supplementary Table S1 .
In vivo wound-healing test
In order to evaluate wound-healing efficiency, the wound closure rate of diabetic ulcers was measured in mice at day 3 and day 7 after treatments. Female C57BL/6 mice (n ¼ 5) were anesthetized and intraperitoneal injection of streptozotocin (60 mg kg À 1 ) was performed to induce diabetic mellitus-like symptoms. After 4 days, the blood glucose level was measured by Accu-Chek Active (Roche, Switzerland). Blood glucose levels of X230 mg dl À 1 were considered diabetic. A burn wound was created in the dorsal area of mice by hot circular metal sticks (f ¼ 9 mm). After 1 day, the dead skin was excised to the full thickness to expose epidermal and dermal layers. No treatment control, MMP-2 siRNA solution (0.15 nmol), LPEI-NF or MMP-2 siRNA-incorporated NF at N/P ratio 32 (NF 32) was administered to the wound. The wounds of treated animals were wrapped with a Tegaderm and Coban (3M Health Care, St Paul, MN, USA) to fix each sample. At day 3 and day 7 after wound-healing treatments, the wound closure rate was determined by calculating the wound area (wound closure rate ¼ (wound area day 0-wound area day #)/wound area day 0). All animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Kangwon National University (KIACUC).
RT-PCR
Re-epithelialized tissues in diabetic ulcers were excised from killed animals and divided into two parts; one was subjected to RT-PCR, while the other was embedded in paraffin for immunohistochemical staining and Gomori's Trimchrome stain. Wound re-epithelialization was determined by measuring the expression levels of keratinocyte-specific markers (keratin 5 and 14). The MMP-2 mRNA levels by wound-healing treatment were examined by RT-PCR. The total RNA of the re-epithelialized skin tissue was extracted using TRIzol reagent in accordance with the manufacturer's instructions. The isolated RNA was reverse transcribed with Omniscript Reverse Transcription for 1 h at 37 1C and amplified by Taq PCR core kit. The PCR was performed as follows: initial denaturation was performed at 94 1C for 3 min, followed by 35 cycles of 94 1C for 30 s, 55 1C for 30 s and 72 1C for 1 min. The primers are described in Supplementary Table S2 . PCR products were separated by 1.5% agarose gel electrophoresis and the band intensities were quantified using an image-analyzing software, AlphaView (Alpha Innotech, Santa Clara, CA, USA).
Histology
Immunohistochemical staining was performed in accordance with the manufacturer's instructions (IHC Select Immunoperoxidase Secondary Detection System). The tissue samples were fixed with 2.5% formaldehyde solution for 1 h and dehydrated in graded ethanol series, then embedded in paraffin. Tissue sections were prepared by a microtome with 4 mm thickness and deparaffinized with xylene and a series of graded ethanol (100, 70 and 30%). Rehydrated tissue sections were subjected to antigen retrieval in 10 mM sodium citrate buffer (pH 6.0) and microwave irradiation for 20 min. After endogenous peroxidase activity was blocked by 3% hydrogen peroxide for 10 min, the section was saturated in goat serum for 5 min. An anti-MMP-2 antibody (rabbit polyclonal IgG, 10 mg ml -1 ) was incubated for 12 h at 4 1C and a secondary antibody (biotinylated goat anti-mouse IgG and goat anti-rabbit IgG) was subsequently incubated for 10 min. The tissue was treated with a streptavidin HRP reagent and was developed in freshly prepared 3,3 0 -diaminobezidine substrate. The tissue was counter-stained with Mayer's hematoxylin for 1 min. For total collagen staining, Gomori's trichrome stainning method was employed: deparaffinized and hydrated sections were incubated in Bouin's Fluid at 56 1C for siRNA nanofibrous meshes for wound healing HS Kim and HS Yoo 1 h, which was followed by incubation in Weigher's iron hematoxylin solution for 10 min. Trichrome solution and 1% acetic acid were sequentially treated for 15 and 1 min, respectively. The developed blue color density of the microscopy images (n ¼ 3) was quantified and normalized with respect to the wound area by an image analysis software (Image-Pro v6.0, Media Cybernetics). The accumulation of neo-collagen fibers (%) was determined by comparing collagen densities of the samples to those of a control group.
